BGC - THE COMPLETE STORY !!!!

alan, absolutely not clear, complete mish mash and obviously no clinical trials but lots of blurb.( edit, insert this, but I do think the FDA have given it the OK). May nick a bit of the market but only Vs has the possibility to replace surgery IF approved as it will (hopefully) be the only clinically trialled treatment. Vs still has value if......and I don't think it will be stopped if trials resumed.

Also if Campath approved for MS (poss 2010) royalties could conceivably approach admin. 96% early trials success rate, fast take up of Phase II trial places, ILEX extremely bullish and taken out, encouraging.

But as allways, jam tomorrow......